vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and WOLVERINE WORLD WIDE INC (WWW). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $517.5M, roughly 1.8× WOLVERINE WORLD WIDE INC). WOLVERINE WORLD WIDE INC runs the higher net margin — 6.1% vs 0.7%, a 5.5% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 25.5%). WOLVERINE WORLD WIDE INC produced more free cash flow last quarter ($145.6M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 14.5%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Wolverine World Wide is a global designer, manufacturer and marketer of branded footwear, apparel and accessories. It owns popular brands including Merrell, Sperry, Saucony and Hush Puppies, serving outdoor, casual, workwear and athletic segments via e-commerce, retail stores and global wholesale networks.
ASTH vs WWW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $517.5M |
| Net Profit | $6.6M | $31.8M |
| Gross Margin | — | 47.3% |
| Operating Margin | 1.9% | 9.7% |
| Net Margin | 0.7% | 6.1% |
| Revenue YoY | 42.9% | 25.5% |
| Net Profit YoY | 184.4% | 162.8% |
| EPS (diluted) | $0.12 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $517.5M | ||
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $470.3M | ||
| Q2 25 | $654.8M | $474.2M | ||
| Q1 25 | $620.4M | $412.3M | ||
| Q4 24 | $665.2M | $494.7M | ||
| Q3 24 | $478.7M | $440.2M | ||
| Q2 24 | $486.3M | $425.2M |
| Q1 26 | — | $31.8M | ||
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $25.1M | ||
| Q2 25 | $9.4M | $26.8M | ||
| Q1 25 | $6.7M | $12.1M | ||
| Q4 24 | $-7.8M | $23.1M | ||
| Q3 24 | $16.1M | $23.2M | ||
| Q2 24 | $19.2M | $13.8M |
| Q1 26 | — | 47.3% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 47.5% | ||
| Q2 25 | — | 47.2% | ||
| Q1 25 | — | 47.2% | ||
| Q4 24 | — | 43.4% | ||
| Q3 24 | — | 45.1% | ||
| Q2 24 | — | 43.1% |
| Q1 26 | — | 9.7% | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 8.4% | ||
| Q2 25 | 3.1% | 8.6% | ||
| Q1 25 | 3.3% | 4.8% | ||
| Q4 24 | 0.1% | 7.4% | ||
| Q3 24 | 5.9% | 7.9% | ||
| Q2 24 | 6.2% | 6.8% |
| Q1 26 | — | 6.1% | ||
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | 5.3% | ||
| Q2 25 | 1.4% | 5.7% | ||
| Q1 25 | 1.1% | 2.9% | ||
| Q4 24 | -1.2% | 4.7% | ||
| Q3 24 | 3.4% | 5.3% | ||
| Q2 24 | 3.9% | 3.2% |
| Q1 26 | — | $0.37 | ||
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $0.30 | ||
| Q2 25 | $0.19 | $0.32 | ||
| Q1 25 | $0.14 | $0.15 | ||
| Q4 24 | $-0.14 | $0.29 | ||
| Q3 24 | $0.33 | $0.28 | ||
| Q2 24 | $0.40 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | — |
| Total DebtLower is stronger | — | $621.7M |
| Stockholders' EquityBook value | $779.3M | $408.0M |
| Total Assets | $2.2B | $1.7B |
| Debt / EquityLower = less leverage | — | 1.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | — |
| Q1 26 | — | $621.7M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $676.4M | ||
| Q2 25 | — | $708.5M | ||
| Q1 25 | — | $710.8M | ||
| Q4 24 | — | $648.0M | ||
| Q3 24 | — | $702.8M | ||
| Q2 24 | — | $814.7M |
| Q1 26 | — | $408.0M | ||
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $376.7M | ||
| Q2 25 | $765.5M | $344.0M | ||
| Q1 25 | $745.4M | $310.6M | ||
| Q4 24 | $712.7M | $312.9M | ||
| Q3 24 | $704.6M | $295.2M | ||
| Q2 24 | $678.9M | $262.1M |
| Q1 26 | — | $1.7B | ||
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $1.4B | $1.8B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.3B | $1.8B | ||
| Q2 24 | $1.3B | $1.8B |
| Q1 26 | — | 1.52× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 2.29× | ||
| Q4 24 | — | 2.07× | ||
| Q3 24 | — | 2.38× | ||
| Q2 24 | — | 3.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $146.2M |
| Free Cash FlowOCF − Capex | $-6.0M | $145.6M |
| FCF MarginFCF / Revenue | -0.6% | 28.1% |
| Capex IntensityCapex / Revenue | 0.3% | 0.1% |
| Cash ConversionOCF / Net Profit | -0.44× | 4.60× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $146.2M | ||
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $33.0M | ||
| Q2 25 | $90.9M | $44.6M | ||
| Q1 25 | $16.6M | $-83.8M | ||
| Q4 24 | $-10.9M | $82.4M | ||
| Q3 24 | $34.0M | $108.2M | ||
| Q2 24 | $23.2M | $26.7M |
| Q1 26 | — | $145.6M | ||
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $30.1M | ||
| Q2 25 | $89.5M | $41.2M | ||
| Q1 25 | $13.6M | $-91.4M | ||
| Q4 24 | $-13.5M | $74.4M | ||
| Q3 24 | $31.7M | $104.1M | ||
| Q2 24 | $20.4M | $23.7M |
| Q1 26 | — | 28.1% | ||
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 6.4% | ||
| Q2 25 | 13.7% | 8.7% | ||
| Q1 25 | 2.2% | -22.2% | ||
| Q4 24 | -2.0% | 15.0% | ||
| Q3 24 | 6.6% | 23.6% | ||
| Q2 24 | 4.2% | 5.6% |
| Q1 26 | — | 0.1% | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 0.6% | ||
| Q2 25 | 0.2% | 0.7% | ||
| Q1 25 | 0.5% | 1.8% | ||
| Q4 24 | 0.4% | 1.6% | ||
| Q3 24 | 0.5% | 0.9% | ||
| Q2 24 | 0.6% | 0.7% |
| Q1 26 | — | 4.60× | ||
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 1.31× | ||
| Q2 25 | 9.65× | 1.66× | ||
| Q1 25 | 2.48× | -6.93× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 2.11× | 4.66× | ||
| Q2 24 | 1.21× | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
WWW
| Sales Channel Through Intermediary | $230.2M | 44% |
| Sales Channel Directly To Consumer | $142.6M | 28% |
| Work Group | $134.0M | 26% |
| Other | $10.7M | 2% |
